Abstract
Background and ImportanceElexacaftor/tezacaftor/ivacaftor (ETI) are bringing about a major change in the treatment of cystic fibrosis (CF) patients. However, continuing with other treatments such as nebulised antibiotics is necessary.Aim and...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have